New vaccines and immunisation products added to the AIR

Additional non-standard vaccines and immunisation products can now be recorded on AIR:

  • Abrysvo (respiratory syncytial virus [RSV])
  • Arexvy (RSV)
  • Beyfortus (nirsevimab – monoclonal antibody for the prevention of RSV)
  • Generic RSV
  • Degvaxia (dengue fever)
  • Generic Dengue
  • Q-Vax (Q fever)
  • Vaxchora (cholera)
  • Vaxneuvance (15-valent pneumococcal conjugate vaccine; available to report to AIR from 22 May 2024).

The list of all vaccines that can be recorded on the AIR is available here.

Ensure you are using the latest version of your software product to access the full range of vaccines available for reporting. Your software vendor can assist you with this.

Share New vaccines and immunisation products added to the AIR on Facebook Share New vaccines and immunisation products added to the AIR on Twitter Share New vaccines and immunisation products added to the AIR on Linkedin Email New vaccines and immunisation products added to the AIR link